Judges Kathleen O’Malley, left, and Kara Stoll, right.
Judge Kathleen O'Malley says the court has been too broadly applying the Supreme Court's Myriad decision for the last four years.
October 10, 2018 at 12:33 PM
1 minute read
The original version of this story was published on National Law Journal
The medical diagnostics industry has found an ally in its quest to restore patent eligibility for groundbreaking discoveries, even those involving natural phenomena.
Judge Kathleen O’Malley of the U.S. Court of Appeals for the Federal Circuit called on the full court to review its case law Tuesday even while voting to affirm the latest invalidation, this time on a Roche patent for quickly diagnosing drug-resistant tuberculosis.
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
This conference brings together the industry's most influential & knowledgeable real estate executives from the net lease sector.
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Duane Morris LLP seeks a highly motivated junior associate to join its dynamic and growing Labor and Employment Class Action group in Chicag...
Duane Morris LLP seeks a full-time staff litigation attorney who has practiced between 3-5 years. Experience will include drafting motions, ...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
